Home > Insider Trading > Filing (0001401708-21-000208)

Filing Details

Accession Number:: 0001401708-21-000208
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-03 17:13:24
Reporting Period:: 2021-09-01

Accepted Time:: 2021-09-03 17:13:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401708	Nanostring Technologies Inc	NSTG	Biological Products, (No Disgnostic Substances) (2836)	200094687

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1576195	M Joseph Beechem	530 Fairview Avenue N Seattle WA 98109	Svp, Research & Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-09-01	209	$51.97	91,384	No	4	A	Direct
Common Stock	Disposition	2021-09-02	13,000	$60.83	78,284	No	4	S	Direct
Common Stock	Disposition	2021-09-02	10,114	$61.54	68,270	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the NanoString Technologies, Inc. Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase Period (as defined in the ESPP) of March 1, 2021 through September 1, 2021. This transaction is also exempt under Rule 16b-3(c).
The Purchase Period ending September 1, 2021 is the PUrchase Period comprising the Offering Period (as defined in the ESPP) that began March 1, 2021 and ended September 1, 2021.
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on September 1, 2021.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $60.24 to $61.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $61.32 to $61.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.